A patient audit of more than 1,000 lupus nephritis charts highlights growing experience with biologics and calcineurin inhibitors, alongside rising off-label adoption of SGLT2 inhibitors.Exton, PA, ...

Servier will acquire Day One Biopharmaceuticals for roughly $2.5 billion. But an analyst says other companies could make ...

U.S. News compares companies to their industry peers based on a variety of company fundamentals, performance metrics and investor preferences to help you find the right stocks for your investing style ...

As surgical complexity rises, the demand for intelligent wound closure has transformed the Surgical Staplers Market from a ...

The company said its Phase II ZUPREME-1 trial in overweight or obese individuals without type 2 diabetes showed weight loss of 10.7% at week 42 on an efficacy estimand basis for t ...

Plenty of new dramas to enjoy this week, from the return of The Capture and Ellis to a new adaptation of A Woman of Substance ...

Uncover the best isometric RPGs that gaming has to offer, ranked by their impeccable gameplay, unmatched storytelling, and ...

Discusses Phase II Results for HLP004 in Generalized Anxiety Disorder March 5, 2026 7:30 AM ESTCompany ParticipantsMichael Cola - ...

Broker upgrades odds on AVANZAR lung cancer trial after arguing repeated delays signal strong results in treatment arm Jefferies has lifted its price target on AstraZeneca PLC (LSE:AZN, NASDAQ:AZN), ...

Enrollment remains on track in Phase 2 pivotal portion of PYNNACLE trial evaluating rezatapopt as monotherapy in platinum-resistant/refractory ovarian cancer patients with a TP53 Y220C ...